ETON
NASDAQ HealthcareEton Pharmaceuticals, Inc. - Common Stock
Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
๐ Market Data
| Price | $28.90 |
|---|---|
| Volume | 960,360 |
| Market Cap | 790.70M |
| Beta | 0.970 |
| RSI (14-Day) | 60.1 |
| 200-Day MA | $18.23 |
| 50-Day MA | $22.02 |
| 52-Week High | $29.79 |
| 52-Week Low | $13.09 |
| Forward P/E | 18.53 |
| Price / Book | 29.89 |
๐ฏ Investment Strategy Scores
ETON scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (61/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ช Falling Knife (9/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find ETON in your text
Paste any article, transcript, or post โ the tool will extract ETON and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.